Enzymatic reduction of polyunsaturated lysophosphati-dylcholine hydroperoxides by glutathione peroxidase-1

European Journal of Lipid Science and Technology

Volumn 111, Issue 6, 2009, Pages 584-592

  Huang, Long Shuang ^a   Kim, Mee Ree ^a   Sok, Dai Eun ^a  

^a Chungnam National University   (South Korea)

Author keywords

Arachidonoyl lysoPC; Docosahexaenoyl lysoPC; Glutathione peroxidase; Hydroperoxides; Lipoxygenase; RBL

Indexed keywords

GLYCINE MAX;

EID: 69849105735     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200900023     Document Type: Article

References (47)

1. F. Ursini, A. Bindoli: The role of selenium peroxidases in the protection against oxidative damage. Chem Phys Lipids. 1987, 44, 255-276.
2. G. C. Mills: Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown. J Biol Chem. 1957, 229, 189-197.
3. J. R. Roberts, C. F. Shaw 3rd: Inhibition of erythrocyte selenium-glutathione peroxidase by auranofin analogues and metabolites. Biochem Pharmacol. 1998, 55, 1291-1299.
4. R. Fukuhara, T. Kageyama: Structure, gene expression, and evolution of primate glutathione peroxidases. Comp Biochem Physiol B Biochem Mol Biol. 2005, 141, 428-436.
5. R. Muralikrishna Adibhatla, J. F. Hatcher: Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med. 2006, 40, 376-387.
6. A. Grossman, A. Wendel: Non-reactivity of the selenoenzyme glutathione peroxidase with enzymatically hydroperoxidized phospholipids. Eur J Biochem. 1983, 135, 549-552.
7. F. Antunes, A. Salvador, R. E. Pinto: PHGPx and phospholipase A2/GPx: Comparative importance on the reduction of hydroperoxides in rat liver mitochondria. Free Radic Biol Med. 1995, 19, 669-677.
8. H. S. Marinho, F. Antunes, R. E. Pinto: Role of glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase in the reduction of lysophospholipid hydroperoxides. Free Radic Biol Med. 1997, 22, 871-883.
9. D. Drissner, G. Kunze, N. Callewaert, P. Gehrig, M. Tamasloukht, T. Boller, G. Felix, N. Amrhein, M. Bucher: Lysophosphatidylcholine is a signal in the arbuscular mycorrhizal symbiosis. Science. 2007, 318, 265-268.
10. T. Matsumoto, T. Kobayashi, K. Kamata: Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem. 2007, 14, 3209-3220.
11. D. Pacetti, E. Boselli, H. W. Hulan, N. G. Frega: High performance liquid chromatography-tandem mass spectrometry of phospholipid molecular species in eggs from hens fed diets enriched in seal blubber oil. J Chromatogr A. 2005, 1097, 66-73.
12. J. Morishige, K. Touchika, T. Tanaka, K. Satouchi, K. Fukuzawa, A. Tokumura: Production of bioactive lysophosphatidic acid by lysophospholipase D in hen egg white. Biochim Biophys Acta. 2007, 1771, 491-499.
13. M. Croset, N. Brossard, A. Polette, M. Lagarde: Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J. 2000, 345, 61-67.
14. S. Chen, K. W. Li: Mass spectrometric identification of molecular species of phosphatidylcholine and lysophosphatidylcholine extracted from shark liver. J Agric Food Chem. 2007, 55, 9670-9677.
15. J. Adachi, M. Asano, N. Yoshioka, H. Nushida, Y. Ueno: Analysis of phosphatidylcholine oxidation products in human plasma using quadrupole time-of-flight mass spectrometry. Kobe J Med Sci. 2006, 52, 127-140.
16. B. Barroso, R. Bischoff: LC-MS analysis of phospholipids and lysophospholipids in human bronchoalveolar lavage fluid. J Chromatogr B Anal Technol Biomed Life Sci. 2005, 814, 21-28.
17. F. Takayama, T. Egashira, Y. Yamanaka: The multiple hydroperoxides of choline phospholipids in plasma after ischemiareperfusion in rat liver. J Toxicol Sci. 1994, 19, 97-106.
18. N. Fang, S. Yu, T. M. Badger: LC-MS/MS analysis of lysophospholipids associated with soy protein isolate. J Agric Food Chem. 2003, 51, 6676-6682.
19. L. S. Huang, M. R. Kim, T. S. Jeong, D. E. Sok: Linoleoyl lysophosphatidic acid and linoleoyl lysophosphatidylcholine are efficient substrates for mammalian lipoxygenases. Biochim Biophys Acta. 2007, 1770, 1062-1070.
20. L. S. Huang, M. R. Kim, D. E. Sok: Oxygenation of 1-docosahexaenoyl lysophosphatidylcholine by lipoxygenases; conjugated hydroperoxydiene and dihydroxytriene derivatives. Lipids. 2007, 42, 981-990.
21. L. S. Huang, J. S. Kang, M. R. Kim, D. E. Sok: Oxygenation of arachidonoyl lysophospholipids by lipoxygenases from soybean, porcine leukocyte, or rabbit reticulocyte. J Agric Food Chem. 2008, 56, 1224-1232.
22. L. S. Huang, M. R. Kim, D. E. Sok: Linoleoyl lysophosphatidylcholine is an efficient substrate for soybean lipoxygenase-1. Arch Biochem Biophys. 2006, 455, 119-126.
23. X. W. Liu, D. E. Sok, H. S. Yook, C. B. Sohn, Y. J. Chung, M. R. Kim: Inhibition of lysophospholipase D activity by unsaturated lysophosphatidic acids or seed extracts containing 1linoleoyl and 1-oleoyl lysophosphatidic acid. J Agric Food Chem. 2007, 55, 8717-8722.
24. D. Nieves, J. J. Moreno: Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation. Biochem Pharmacol. 2006, 72, 1022-1030.
25. R. Yamazaki, R. Aiyama, T. Matsuzaki, S. Hashimoto, T. Yokokura: Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice. Inflamm Res. 1998, 47, 182-186.
26. A. Wendel: Glutathione peroxidase. Methods Enzymol. 1981, 77, 393-397.
27. H. S. Cui, M. R. Kim, D. E. Sok: Protection by petaslignolide A, a major neuroprotective compound in the butanol extract of Petasites japonicus leaves, against oxidative damage in the brains of mice challenged with kainic acid. J Agric Food Chem. 2005, 53, 8526-8532.
28. L. S. Huang, M. R. Kim, D. E. Sok: Regulation of lipoxygenase activity by polyunsaturated lysophosphatidylcholines or their oxygenation derivatives. J Agric Food Chem. 2008, 56, 7808-7814.
29. L. T. Kang, J. Y. Vanderhoek: Characterization of specific subcellular 15-hydroxyeicosatetraenoic acid (15-HETE) binding sites on rat basophilic leukemia cells. Biochim Biophys Acta. 1995, 1256, 297-304.
30. 44-synthase activity. Biochim Biophys Acta. 1992, 1128, 14-25.
31. H. Imai, D. Sumi, H. Sakamoto, A. Hanamoto, M. Arai, N. Chiba, Y. Nakagawa: Overexpression of phospholipid hydroperoxide glutathione peroxidase suppressed cell death due to oxidative damage in rat basophile leukemia cells (RBL-2H3). Biochem Biophys Res Commun. 1996, 222, 432-438.
32. M. Pérez-Gilabert, G. A. Veldink, J. F. Vliegenthart: Oxidation of dilinoleoyl phosphatidylcholine by lipoxygenase 1 from soybeans. Arch Biochem Biophys. 1998, 354, 18-23.
33. J. Aoki: Mechanisms of lysophosphatidic acid production. Semin Cell Dev Biol. 2004, 15, 477-489.
34. C. H. Macphee, J. J. Nelson, A. Zalewski: Lipoprotein-associated phospholipase A2 as a target of therapy. Curr Opin Lipidol. 2005, 16, 442-446.
35. M. Gauster, G. Rechberger, A. Sovic, G. Hörl, E. Steyrer, W. Sattler, S. Frank: Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J Lipid Res. 2005, 46, 1517-1525.
36. M. Lagarde, N. Bernoud, N. Brossard, D. Lemaitre-Delaunay, F. Thiès, M. Croset, J. Lecerf: Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. J Mol Neurosci. 2001, 16, 201-204.
37. F. Thies, M. C. Delachambre, M. Bentejac, M. Lagarde, J. Lecerf: Unsaturated fatty acids esterified in 2-acyl-llysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J Neurochem. 1992, 59, 1110-1116.
38. R. Margis, C. Dunand, F. K. Teixeira, M. Margis-Pinheiro: Glutathione peroxidase family an evolutionary overview. FEBS J. 2008, 275, 3959-3970.
39. L. Zhang, M. Maiorino, A. Rovelli, F. Ursini: Phospholipid hydroperoxide glutathione peroxidase: Specific activity in tissues of rats of different age and comparison with other glutathione peroxidases. Biochim Biophys Acta 1989, 1006, 140-143.
40. G. Subbanagounder, A. D. Watson, J. A. Berliner: Bioactive products of phospholipid oxidation: Isolation, identification, measurement and activities. Free Radic Biol Med. 2000, 28, 1751-1761.
41. J. L. Witztum, D. Steinberg: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991, 88, 1785-1792.
42. S. Yamagishi, K. Nakamura, T. Matsui: Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine. Curr Med Chem. 2008, 15, 172-177.
43. R. Levy: The role of cytosolic phospholipase A2-alfa in regulation of phagocytic functions. Biochim Biophys Acta. 2006, 1761, 1323-1334.
44. V. Nambi, R. C. Hoogeveen, L. Chambless, Y. Hu, H. Bang, J. Coresh, H. Ni, E. Boerwinkle, T. Mosley, R. Sharrett, A. R. Folsom, C. M. Ballantyne: Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2009, 40, 376-381.
45. M. S. Elkind, W. Tai, K. Coates, M. C. Paik, R. L. Sacco: Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke. Cerebrovasc Dis. 2009, 27, 42-50.
46. N. R. Webb: Secretory phospholipase A2 enzymes in atherogenesis. Curr Opin Lipidol. 2005, 16, 341-344.
47. Y. Ishimoto, K. Yamada, S. Yamamoto, T. Ono, M. Notoya, K. Hanasaki: Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions. Biochim Biophys Acta. 2003, 1642, 129-138.